Bill Guo, Ph.D.
Chairman of the Board and Acting CEO
Dr. Guo is the Chairman and founder of Venturepharm Group, a leading full service pharmaceutical company in Asia, and led its flagship Venturepharm Laboratories, Ltd. to become the first CRO company listed on the Hong Kong Stock Exchange. Dr. Guo has over ten years of experience in the global pharmaceutical industry in positions ranging from researcher to senior executive at Johnson & Johnson, Novapharm and Venturepharm Canada. Dr. Guo has over eight years of experience as an entrepreneur in China. Dr. Guo received a Ph.D. in pharmaceutics and an MSC degree in industrial pharmacy from the University of Toronto, an MBA program certificate from Herriot Watt University and an Executive Education certificate from the Judge Business School at the University of Cambridge. Mr. Guo has been recognized by Fortune magazine as one of the top emerging entrepreneurs in China. He has also been the recipient of various awards, including: the State Council of China’s National Hero Award in 2005; China’s top ten elite in management in 2004; China’s top ten most influential individuals in business in 2005; Business Week Asia’s Youth Chinese Entrepreneur Award in 2005; and the British Chamber of Commerce Entrepreneurs and Innovation Award in 2005.
Richard J. Freer, Ph.D.
COO
Since founding Commonwealth Biotechnologies, Inc., in 1992 with three other partners, Dr. Freer has served as Chairman of the Board and as a Director of the Company. From 1975 until 1997, Dr. Freer was employed in the Department of Pharmacology and Toxicology at Virginia Commonwealth University, rising through the academic ranks to full Professor. In addition, from 1988-1995, Dr. Freer was first Director and then Chair of the Biomedical Engineering Program. Freer received the Bachelor's degree in Biology/Chemistry from Marist College, Poughkeepsie, NY, and the Doctoral degree from Columbia University in Pharmacology. Dr. Freer is the co-author of more than 150 peer reviewed journal articles and book chapters, in his area of research expertise, molecular pharmacology, peptide receptors, and is a co-inventor of 2 US patents. Dr. Freer is a former Established Investigator of the American Heart Association and a National Institutes of Health Fogarty Senior International Fellow.
Robert B. Harris, Ph.D.
President
Dr. Harris has served continuously as the President of CBI since co-founding the company in 1992 with three partners. For 2000-2007, Harris was Chief Executive Officer, and he also served as a Director of the Company from 1997-2008. Until 1997, Dr. Harris was employed in the Department of Biochemistry and Molecular Biophysics at Virginia Commonwealth University, rising through the academic ranks to full Professor. Dr. Harris received a joint Bachelor's degree in Chemistry and Biology from the University of Rochester, Rochester, NY, and the Master's and Doctoral degrees from New York University, in Biochemistry and Biophysical Chemistry. Dr. Harris is the co-author of more than 75 peer reviewed journal articles and book chapters, mostly in areas of his research expertise: the role of macromolecular structure in biological function. Dr. Harris is a former Established Investigator of the American Heart Association, and is co-inventor of US and foreign patents.Thomas R. Reynolds, B.S.
Executive Vice President, Science & Technology
Since founding Commonwealth Biotechnologies, Inc., in 1992 with three other partners, Mr. Reynolds has served as Vice President, Senior Vice President and Executive Vice President as well as a Director of the Company. Unitl recently, Mr. Reynolds was Secretary of the Board of Directors.. Mr. Reynolds is responsible for oversight of all DNA related technologies and services including management oversight of the Fairfax Identity Laboratory division. From 1987 until 1997, Mr. Reynolds served as Manager of the Nucleic Acids Core Laboratory at The Massey Cancer Center in the Department of Microbiology Biology and Immunology at Virginia Commonwealth University. From 1984 through 1986, Reynolds served as a research assistant in Genetics at Carnegie Mellon University. Mr. Reynolds is a co-inventor of several US patents, and co-author of more than 35 peer reviewed journal articles and book chapters, in the research area of molecular genetics.
James H. Brennan, M.B.A.
Vice President, Financial Operations
James H. Brennan was promoted to Vice President, Financial Operations in December 2005 and continues to serve as an officer of the Company. From 1997 until 2005, Mr. Brennan was previously Controller for the Company. During his tenure, Mr. Brennan is responsible finance and accounting, treasury, human resources and investor relations. Prior to joining the Company, (1988 until 1997), Mr. Brennan's other work experience included, corporate controller for Star Tobacco and Pharmaceuticals, Delta Airport Consultants, Herald Pharmaceuticals and, Christian Children's Fund. From 1980 until 1988, Mr. Brennan worked for the Coca Cola Bottling Company as Plant Controller, Systems Analyst and Corporate Accounting Manager. Mr. Brennan holds a BA from Mount Saint Mary's College and an MBA from Averett University.